Vote Scores
Filings read through

AstraZeneca PLC: how funds voted at the meeting of 9 Apr 2026

Ticker
AZN
Meeting
Season
year to 30 June 2026
Filers reporting
934
Ballot items
10

934 filers on Form N-PX reported votes at the AstraZeneca PLC meeting of 9 Apr 2026. The records fall into 10 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    13 nominees. 75.8% of the reported votes are for. 122 filers withheld from or voted against at least one nominee.

    18,112 vote records from 448 filers. 1 of the 443 filers that marked the item voted against management. 5 filers gave no management mark.

    • Positions of 56 fund families
    • For 56
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    933 vote records from 577 filers. 5 of the 553 filers that marked the item voted against management. 24 filers gave no management mark.

    • Positions of 16 fund families
    • For 16
  3. Item 3: Audit-related items (auditor ratification)

    2,790 vote records from 446 filers. 0 of the 440 filers that marked the item voted against management. 6 filers gave no management mark.

    • Positions of 56 fund families
    • For 56
  4. Item 4: SHAREHOLDER RIGHTS AND DEFENSES: management items

    The company's items in this category are shown together, because filers word and number them differently.

    111 vote records from 35 filers. 0 of the 35 filers that marked the item voted against management.

    • Positions of 2 fund families
    • For 2
  5. Item 5: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    6,232 vote records from 446 filers. 1 of the 440 filers that marked the item voted against management. 6 filers gave no management mark.

    • Positions of 56 fund families
    • For 56
  6. Item 6: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    1,870 vote records from 445 filers. 1 of the 439 filers that marked the item voted against management. 6 filers gave no management mark.

    • Positions of 56 fund families
    • For 56
  7. Item 7: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    3,820 vote records from 442 filers. 1 of the 436 filers that marked the item voted against management. 6 filers gave no management mark.

    • Positions of 56 fund families
    • For 54
    • Against 1
    • Split or no vote 1
    • Against management 1
  8. Item 8: OTHER SOCIAL ISSUES: management items

    The company's items in this category are shown together, because filers word and number them differently.

    1,030 vote records from 435 filers. 4 of the 430 filers that marked the item voted against management. 5 filers gave no management mark.

    • Positions of 56 fund families
    • For 55
    • Against 1
    • Against management 1
  9. Item 9: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    186 vote records from 73 filers. 0 of the 70 filers that marked the item voted against management. 3 filers gave no management mark.

    • Positions of 9 fund families
    • For 9
  10. Item 10: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    12 vote records from 1 filer. 0 of the 1 filer that marked the item voted against management.

    • Positions of one fund family
    • For 1

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at AstraZeneca PLC, meeting of 9 Apr 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinNo reportFor
AllspringNo reportFor
American BeaconNo reportFor
American CenturyNo reportFor
BairdForNo report
BlackRock and iSharesForFor
BNY MellonNo reportFor
Brighthouse FundsForFor
Capital Group and American FundsNo reportFor
Charles SchwabNo reportFor
Columbia ThreadneedleNo reportFor
DimensionalNo reportFor
DWSNo reportFor
EquitableNo reportFor
Federated HermesNo reportFor
FidelityNo reportFor
First TrustForFor
Franklin TempletonNo reportFor
Global XNo reportFor
Goldman SachsForFor
Guggenheim and RydexNo reportFor
Harbor FundsForFor
Harris Associates and OakmarkNo reportFor
Hartford FundsNo reportFor
InvescoNo reportFor
J.P. MorganForFor
Jackson National fundsForFor
Janus HendersonNo reportFor
John Hancock and ManulifeForFor
Lincoln FinancialForFor
Lord AbbettNo reportFor
Macquarie and Delaware FundsNo reportFor
MassMutualForFor
MFSNo reportFor
Morgan Stanley, Eaton Vance and CalvertNo reportFor
NationwideNo reportFor
Natixis and Loomis SaylesForFor
Neuberger BermanNo reportFor
Northern Trust and FlexSharesForFor
Nuveen and TIAANo reportFor
Pacific Life fundsNo reportFor
PGIM and PrudentialForFor
PIMCONo reportFor
PrincipalNo reportFor
ProShares and ProFundsNo reportFor
Russell InvestmentsNo reportFor
SEINo reportFor
State Street and SPDRNo reportFor
T. Rowe PriceNo reportFor
ThriventNo reportFor
TransamericaForFor
VanEckNo reportFor
VanguardForFor
Victory CapitalNo reportFor
VirtusNo reportFor
VoyaNo reportFor
WisdomTreeNo reportFor

Questions

How many filers reported votes at the AstraZeneca PLC meeting?
934 Form N-PX filers reported votes at the meeting of 9 Apr 2026. On say-on-pay, 5 of 553 filers that marked the item voted against management (0.9%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. AstraZeneca PLC reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list AstraZeneca PLC with a meeting date within three days of 9 Apr 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .